• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Oncology

Specific BRCA1/BRCA2 mutations linked to breast and ovarian cancer risk

byJohn PrendergassandPriyanka Vedak
April 7, 2015
in Oncology, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Multiple breast cancer cluster regions (BCCRs) and ovarian cancer cluster regions (OCCRs) were identified in BRCA1 and BRCA2 genes and were found to confer varying degrees of risk for breast and ovarian cancer.

Evidence Rating Level: 2 (Good)

Study Rundown: BRCA1 and BRCA2 (i.e., breast cancer susceptibility genes) are human genes responsible for producing tumor suppressor proteins, which help repair damaged DNA. While it is currently recognized that mutations to BRCA1 and BRCA2 increase breast and ovarian cancer risk, our understanding of the influence of single specific mutations in the genes is limited.

The authors of this study consequently aimed to identify the influence of the various types and locations of mutations within these genes by performing an observational study on women identified as having pathogenic BRCA1 or BRCA2 mutations. Several breast and ovarian cancer mutation regions were identified in either gene that were associated with relative increases in breast versus ovarian cancer. Strengths of this study include its large sample size from 33 countries, the absence of exclusion of any races or ethnicities, and the variety of BRCA1/2 mutations examined. The study was limited in that there was inadequate power to fully assess the statistical significance of some of the mutations. Nevertheless, with additional studies further validating these results, the findings of this study may eventually be used in the physician’s office to more accurately determine cancer risk and appropriate preventative measures in women with BRCA1/2 mutations.

Click to read the study, published today in JAMA

Relevant Reading: Variation in BRCA1 Cancer Risks by Mutation Position

RELATED REPORTS

#VisualAbstract: Elinzanetant Effectively Reduces Vasomotor Symptoms from Endocrine Therapy for Breast Cancer

Imlunestrant extends progression-free survival in ER-positive, HER2-negative breast cancer

Less frequent mammography is non-inferior to annual screening for breast cancer survival in women after curative treatment

In-Depth [retrospective cohort]: This study evaluated 19 581 female carriers of BRCA1 mutations and 11 900 carriers of BRCA2 mutations between 1937-2011 from 33 countries. Relative hazard ratios (RHR) for breast and ovarian cancer were identified, with values over 1 indicating an increased risk of breast cancer and with values less than 1 indicating an increased risk of ovarian cancer. Mean age of breast cancer diagnosis was 39.9 years in BRCA1 mutation carriers and 42.8 years in BRCA2 mutation carriers. Mean age of ovarian cancer diagnosis was 50 years in BRCA1 mutation carriers and 54.5 years in BRCA2 mutation carriers. A BRCA1 ovarian cancer cluster region (OCCR) contained within exon 11 suggested a relative decrease in breast cancer and increase in ovarian cancer risk (RHR 0.62; 95%CI 0.56-0.70; FDR-corrected p = 9×10−17). Mutations occurring in the 5′ and 3′ regions of BRCA1 resulted in a relative increase in breast cancer risk and a relative decrease in ovarian cancer risk, defining two breast cancer cluster regions (BCCRs). Similarly, a BRCA2 OCCR was uncovered to increase risk of ovarian cancer vs. breast cancer (RHR 0.51; 95%CI 0.44-0.60; p = 6×10−17). Three BRCA2 BCCRs were found to increase breast cancer risk while decreasing ovarian cancer risk.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: brcaBreast Cancer
Previous Post

Specific commercial weight loss programs linked with greater weight loss than education or behavioral counseling

Next Post

Small molecule drug may improve cancer-killing efficacy of oncolytic virus [PreClinical]

RelatedReports

#VisualAbstract: Elinzanetant Effectively Reduces Vasomotor Symptoms from Endocrine Therapy for Breast Cancer
StudyGraphics

#VisualAbstract: Elinzanetant Effectively Reduces Vasomotor Symptoms from Endocrine Therapy for Breast Cancer

June 17, 2025
One-year of Herceptin preferable to two-year regimen
Oncology

Imlunestrant extends progression-free survival in ER-positive, HER2-negative breast cancer

April 11, 2025
3D mammography (tomosynthesis) enhances accuracy of breast cancer screening
Chronic Disease

Less frequent mammography is non-inferior to annual screening for breast cancer survival in women after curative treatment

April 2, 2025
#VisualAbstract Lack of sentinel-lymph node biopsy does not alter survival in early invasive breast cancer
StudyGraphics

#VisualAbstract Lack of sentinel-lymph node biopsy does not alter survival in early invasive breast cancer

March 27, 2025
Next Post
Small molecule drug may improve cancer-killing efficacy of oncolytic virus [PreClinical]

Small molecule drug may improve cancer-killing efficacy of oncolytic virus [PreClinical]

Increased risk of subsequent melanoma after first melanoma diagnosis

Patients prefer notification of skin biopsy results by phone

Adolescents’ muscle strength associated with lower cardiometabolic risk

Recommended physical activity may provide near-maximal longevity benefit

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Tirzepatide-associated improvements in cardiometabolic risk factors linked to degree of weight loss
  • Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
  • 2 Minute Medicine Rewind June 23, 2025
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.